Chemistry: analytical and immunological testing – Peptide – protein or amino acid – Glycoproteins
Patent
1988-04-27
1989-06-06
Foelak, Morton
Chemistry: analytical and immunological testing
Peptide, protein or amino acid
Glycoproteins
436 79, 424 2, G01N 3320, G01N 3300, G01N 100, G01N 3348
Patent
active
048371645
ABSTRACT:
Methods for diagnosing, monitoring and controlling the onset and progression of certain dementias, such as AD. The onset and progression of dementia are diagnosed and monitored by following changes in the relative concentrations of two forms of albumin in either serum or CSF. The onset and progression of dementia are controlled and memory loss is impeded or the impairment of memory is improved by dietary supplementation or the administration of Mg.
REFERENCES:
patent: 4654313 (1987-03-01), Hartman
patent: 4709094 (1987-11-01), Weber et al.
patent: 4728605 (1988-03-01), Fudenberg et al.
Azpuru Carlos
Bionix Corporation
Foelak Morton
LandOfFree
Methods for diagonosing, monitoring and controlling the onset an does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods for diagonosing, monitoring and controlling the onset an, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for diagonosing, monitoring and controlling the onset an will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-40367